FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ATXN10-ZNF354A

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ATXN10-ZNF354A
FusionPDB ID: 8381
FusionGDB2.0 ID: 8381
HgeneTgene
Gene symbol

ATXN10

ZNF354A

Gene ID

25814

6940

Gene nameataxin 10zinc finger protein 354A
SynonymsE46L|HUMEEP|SCA10EZNF|HEL104|HKL1|KID-1|KID1|TCF17
Cytomap

22q13.31

5q35.3

Type of geneprotein-codingprotein-coding
Descriptionataxin-10brain protein E46 homologspinocerebellar ataxia type 10 proteinzinc finger protein 354Aepididymis luminal protein 104transcription factor 17zinc finger protein eZNF
Modification date2020031320200313
UniProtAcc

Q9UBB4

Main function of 5'-partner protein: FUNCTION: Necessary for the survival of cerebellar neurons. Induces neuritogenesis by activating the Ras-MAP kinase pathway. May play a role in the maintenance of a critical intracellular glycosylation level and homeostasis. {ECO:0000250}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000252934, ENST00000381061, 
ENST00000402380, ENST00000498009, 
ENST00000335815, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score16 X 12 X 11=21122 X 2 X 2=8
# samples 192
** MAII scorelog2(19/2112*10)=-3.47453851102751
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(2/8*10)=1.32192809488736
Fusion gene context

PubMed: ATXN10 [Title/Abstract] AND ZNF354A [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ATXN10 [Title/Abstract] AND ZNF354A [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ATXN10(46136418)-ZNF354A(178154126), # samples:1
Anticipated loss of major functional domain due to fusion event.ATXN10-ZNF354A seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ATXN10-ZNF354A seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneATXN10

GO:0031175

neuron projection development

16498633



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr22:46136418/chr5:178154126)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ATXN10 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ZNF354A (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000381061ATXN10chr2246136418+ENST00000335815ZNF354Achr5178154126-350012472663031921
ENST00000252934ATXN10chr2246136418+ENST00000335815ZNF354Achr5178154126-369114382653222985

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000381061ENST00000335815ATXN10chr2246136418+ZNF354Achr5178154126-0.0005051490.9994948
ENST00000252934ENST00000335815ATXN10chr2246136418+ZNF354Achr5178154126-0.0004245620.99957544

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ATXN10-ZNF354A

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ATXN10chr2246136418ZNF354Achr51781541261247327GNLCYKNKDNQDKVSLTFEDVAVLFT
ATXN10chr2246136418ZNF354Achr51781541261438391GNLCYKNKDNQDKVSLTFEDVAVLFT

Top

Potential FusionNeoAntigen Information of ATXN10-ZNF354A in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ATXN10-ZNF354A_46136418_178154126.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B14:01NQDKVSLTF0.97370.7108918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B14:02NQDKVSLTF0.97370.7108918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:01NQDKVSLTF0.97330.7746918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:08NQDKVSLTF0.91630.8459918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:01NQDKVSLTF0.91430.7851918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:18NQDKVSLTF0.91070.6142918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:02NQDKVSLTF0.89470.8933918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:25NQDKVSLTF0.88130.8781918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:13NQDKVSLTF0.84780.7927918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:03NQDKVSLTF0.83830.6517918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B38:02NQDKVSLTF0.8130.8203918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B38:01NQDKVSLTF0.80230.83918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:01NQDKVSLTF0.74470.8182918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B13:01NQDKVSLTF0.72850.7966918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-A32:13NQDKVSLTF0.58780.9261918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:13KDNQDKVSL0.57040.8763716
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B52:01NQDKVSLTF0.16560.6638918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B13:01KDNQDKVSLTF0.99750.9341718
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B14:03DNQDKVSL0.99570.9074816
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C05:09NQDKVSLTF0.99970.9581918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:07NQDKVSLTF0.99960.7705918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:10NQDKVSLTF0.99960.7729918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:15NQDKVSLTF0.99910.9669918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:13NQDKVSLTF0.97430.8626918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:29NQDKVSLTF0.96510.8878918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:27NQDKVSLTF0.9560.9264918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C03:14NQDKVSLTF0.95460.978918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:67NQDKVSLTF0.92760.8921918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:80NQDKVSLTF0.92760.8921918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:10NQDKVSLTF0.92580.9249918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:46NQDKVSLTF0.92090.6961918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:14NQDKVSLTF0.91960.7655918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:03NQDKVSLTF0.91570.9799918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:12NQDKVSLTF0.90980.7918918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:95NQDKVSLTF0.90980.5122918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:06NQDKVSLTF0.90520.8499918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:21NQDKVSLTF0.89420.8805918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:31NQDKVSLTF0.88110.8008918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:05NQDKVSLTF0.86770.7906918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:13NQDKVSLTF0.85230.9594918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:04NQDKVSLTF0.85230.9594918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:08KDNQDKVSL0.84470.6827716
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:05NQDKVSLTF0.80430.7653918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B14:03NQDKVSLTF0.67940.734918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:08NQDKVSLTF0.6750.765918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C12:16NQDKVSLTF0.67270.9638918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B51:07NQDKVSLTF0.13760.604918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:05NKDNQDKVSL0.9940.8803616
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B08:12DNQDKVSL0.98060.6458816
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C05:01NQDKVSLTF0.99970.9581918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:01NQDKVSLTF0.99960.7705918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:03NQDKVSLTF0.99960.8213918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C18:01NQDKVSLTF0.99940.783918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:02NQDKVSLTF0.99910.9669918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:50NQDKVSLTF0.97530.8272918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:34NQDKVSLTF0.97330.7746918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:33NQDKVSLTF0.97330.7746918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:125NQDKVSLTF0.97330.7746918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:27NQDKVSLTF0.96990.8127918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:135NQDKVSLTF0.96210.7518918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C03:67NQDKVSLTF0.950.966918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:24NQDKVSLTF0.94660.7045918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:02NQDKVSLTF0.93550.7892918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:04NQDKVSLTF0.93430.8936918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:02NQDKVSLTF0.92760.8921918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:31NQDKVSLTF0.91930.7876918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C07:17NQDKVSLTF0.91710.9661918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C08:01NQDKVSLTF0.91570.9799918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:12NQDKVSLTF0.91230.7783918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C04:04NQDKVSLTF0.89870.8095918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:39NQDKVSLTF0.8930.7346918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:23NQDKVSLTF0.87830.8521918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:20NQDKVSLTF0.86410.8789918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:20NQDKVSLTF0.8540.8883918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:28NQDKVSLTF0.85190.8765918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B48:02NQDKVSLTF0.83810.8587918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:11NQDKVSLTF0.83680.7262918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:04NQDKVSLTF0.82540.8282918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:24NQDKVSLTF0.80790.8054918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B38:05NQDKVSLTF0.80230.83918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:53NQDKVSLTF0.80050.757918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:06NQDKVSLTF0.79680.8393918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B35:13NQDKVSLTF0.79080.8538918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:07NQDKVSLTF0.77670.765918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:54NQDKVSLTF0.7760.7223918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:73NQDKVSLTF0.77310.6265918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:08NQDKVSLTF0.74740.6965918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:05NQDKVSLTF0.74470.8182918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:13NQDKVSLTF0.73970.6077918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:11NQDKVSLTF0.7120.699918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:03NQDKVSLTF0.70530.8051918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-C12:02NQDKVSLTF0.6970.9746918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:02KDNQDKVSL0.680.8813716
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:30NQDKVSLTF0.57880.7643918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B15:09NQDKVSLTF0.53620.5363918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B07:13NQDKVSLTF0.04090.8209918
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B39:11NKDNQDKVSL0.96340.7253616
ATXN10-ZNF354Achr2246136418chr51781541261438HLA-B18:04DNQDKVSLTF0.90590.9586818

Top

Potential FusionNeoAntigen Information of ATXN10-ZNF354A in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of ATXN10-ZNF354A

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6224NKDNQDKVSLTFEDATXN10ZNF354Achr2246136418chr51781541261438

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ATXN10-ZNF354A

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6224NKDNQDKVSLTFED-7.15543-7.26883
HLA-B14:023BVN6224NKDNQDKVSLTFED-4.77435-5.80965
HLA-B52:013W396224NKDNQDKVSLTFED-6.80875-6.92215
HLA-B52:013W396224NKDNQDKVSLTFED-4.20386-5.23916
HLA-A11:014UQ26224NKDNQDKVSLTFED-7.5194-8.5547
HLA-A11:014UQ26224NKDNQDKVSLTFED-6.9601-7.0735
HLA-A24:025HGA6224NKDNQDKVSLTFED-7.52403-7.63743
HLA-A24:025HGA6224NKDNQDKVSLTFED-5.82433-6.85963
HLA-B27:056PYJ6224NKDNQDKVSLTFED-3.28285-4.31815
HLA-B44:053DX86224NKDNQDKVSLTFED-5.91172-6.94702
HLA-B44:053DX86224NKDNQDKVSLTFED-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ATXN10-ZNF354A

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ATXN10-ZNF354Achr2246136418chr5178154126616NKDNQDKVSLAATAAAGATAACCAAGACAAGGTGTCACTG
ATXN10-ZNF354Achr2246136418chr5178154126716KDNQDKVSLAAAGATAACCAAGACAAGGTGTCACTG
ATXN10-ZNF354Achr2246136418chr5178154126718KDNQDKVSLTFAAAGATAACCAAGACAAGGTGTCACTGACGTTT
ATXN10-ZNF354Achr2246136418chr5178154126816DNQDKVSLGATAACCAAGACAAGGTGTCACTG
ATXN10-ZNF354Achr2246136418chr5178154126818DNQDKVSLTFGATAACCAAGACAAGGTGTCACTGACGTTT
ATXN10-ZNF354Achr2246136418chr5178154126918NQDKVSLTFAACCAAGACAAGGTGTCACTGACGTTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of ATXN10-ZNF354A

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SKCMATXN10-ZNF354Achr2246136418ENST00000252934chr5178154126ENST00000335815TCGA-BF-A5EQ-01A

Top

Potential target of CAR-T therapy development for ATXN10-ZNF354A

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ATXN10-ZNF354A

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ATXN10-ZNF354A

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource